Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-02-25
DOI
10.1111/jvh.12886
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials
- (2017) Zobair Younossi et al. Health and Quality of Life Outcomes
- Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation
- (2017) Noriko Oza et al. HEPATOLOGY RESEARCH
- In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered
- (2017) Zobair Younossi et al. LIVER INTERNATIONAL
- Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease
- (2017) Fumihiro Ogata et al. ONCOLOGY
- Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety
- (2017) Nyan L Latt et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatitis C virus infection
- (2017) Michael P. Manns et al. Nature Reviews Disease Primers
- Cost–utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan
- (2016) Ataru Igarashi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response
- (2016) Norah A. Terrault et al. GASTROENTEROLOGY
- JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2
- (2016) Yasuhiro Asahina et al. HEPATOLOGY RESEARCH
- The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study
- (2016) Hiromitsu Kumada et al. JOURNAL OF GASTROENTEROLOGY
- Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences
- (2016) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society?
- (2016) Zobair M. Younossi et al. LIVER INTERNATIONAL
- The impact of hepatitis C virus outside the liver: Evidence from Asia
- (2016) Zobair M. Younossi et al. LIVER INTERNATIONAL
- Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes
- (2016) Arnolfo Petruzziello et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
- (2015) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life
- (2015) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
- (2015) Jagpreet Chhatwal et al. ANNALS OF INTERNAL MEDICINE
- Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection
- (2015) Stefan Zeuzem et al. ANNALS OF INTERNAL MEDICINE
- Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes
- (2015) Hamish A. Innes et al. HEPATOLOGY
- Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis
- (2015) Hiromitsu Kumada et al. HEPATOLOGY
- Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
- (2015) Masashi Mizokami et al. LANCET INFECTIOUS DISEASES
- The impact of hepatitis C burden: an evidence-based approach
- (2014) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Changes in hepatitis C virus genotype distribution in Japan
- (2014) H. TOYODA et al. EPIDEMIOLOGY AND INFECTION
- Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
- (2014) D Hartwell et al. HEALTH TECHNOLOGY ASSESSMENT
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
- (2012) Roberta D'Ambrosio et al. HEPATOLOGY
- Chronic hepatitis C virus (HCV) disease burden and cost in the United States
- (2012) Homie Razavi et al. HEPATOLOGY
- A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C
- (2011) Jules L. Dienstag et al. HEPATOLOGY
- Economic burden of hepatitis C-associated diseases in the United States
- (2011) A. C. El Khoury et al. JOURNAL OF VIRAL HEPATITIS
- A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
- (2011) William Sievert et al. LIVER INTERNATIONAL
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2010) Fasiha Kanwal et al. GASTROENTEROLOGY
- Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection
- (2010) Yasuhiro Asahina et al. HEPATOLOGY
- Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
- (2010) Ana-Carolina Cardoso et al. JOURNAL OF HEPATOLOGY
- Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
- (2008) Sarah Maylin et al. GASTROENTEROLOGY
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
- The burden of illness associated with hepatocellular carcinoma in the United States
- (2008) Kathleen Lang et al. JOURNAL OF HEPATOLOGY
- Cost-Effectiveness of the National Screening Program for Hepatitis C Virus in the General Population and the High-Risk Groups
- (2008) Junichiro Nakamura et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More